These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 838527)

  • 1. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influencing the effect of Dirastan (tolbutamide) simultaneous administration of chloramphenicol in patients with diabetes and bacterial urinary tract inflammation (author's transl)].
    Brunová E; Slabochová Z; Platilová H
    Cas Lek Cesk; 1974 Jan; 113(3):72-5. PubMed ID: 4434411
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolbutamide serum levels im chloramfenicol treated diabetic females (author's transl)].
    Brunová E; Slabochová Z; Platilová H; Pavlík F; Grafnetterová J; Dvorácek K
    Cas Lek Cesk; 1974 Nov; 113(48):1484-7. PubMed ID: 4434421
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extreme hypoglycemia during combined tolbutamide, n-1-butylbiguanide hydrochloride and chloramphenicol therapy].
    Ziegelasch HJ
    Z Gesamte Inn Med; 1972 Jan; 27(2):63-6. PubMed ID: 5022999
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recurrent hypoglycemic coma due to abnormal degradation of tolbutamide].
    Schulz E; Brinkmann W
    Dtsch Med Wochenschr; 1968 Mar; 93(11):485-91. PubMed ID: 5638113
    [No Abstract]   [Full Text] [Related]  

  • 6. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Considerations apropos of severe and prolonged hypoglycemia occurring in an aged patient under treatment with sulfanylurea].
    Barbieri R; Michetti A
    Policlinico Prat; 1967 Sep; 74(37):1263-9. PubMed ID: 5615909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe hypoglycemia due to Dirastan (tolbutamide) in a diabetic with chronic renal failure].
    Bures J; Fixa B; Kaut V; Herout V; Hrncír Z
    Vnitr Lek; 1982 Jul; 28(7):678-84. PubMed ID: 7112992
    [No Abstract]   [Full Text] [Related]  

  • 9. The oral antidiabetic agents.
    Bierman EL
    Am Fam Physician; 1976 Jan; 13(1):98-104. PubMed ID: 1251792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary cyclic 3',5'-adenosine monophosphate (cAMP) in diabetic subjects with and without symptomatic hypoglycemia and in normal subjects with insulin-induced hypoglycemia.
    Lilienfeld-Toal H; Willms B
    Horm Metab Res; 1976 Jul; 8(4):279-81. PubMed ID: 182632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
    Fedeli S; Maglia A
    Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glycemia and plasma insulin under the influence of tolbutamide and HB 419 in normal and diabetic persons].
    Quabbe HJ; Kliems G
    Journ Annu Diabetol Hotel Dieu; 1969; 10():301-9. PubMed ID: 5376989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
    Hasslacher C; Wahl P
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus.
    Queale WS; Seidler AJ; Brancati FL
    Arch Intern Med; 1997 Mar; 157(5):545-52. PubMed ID: 9066459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-diabetic drugs as a cause of hypoglycaemia among acute medical admissions in Hong Kong and Singapore--relationship to the prescribing patterns in diabetic patients.
    Chan TY
    Singapore Med J; 1998 Apr; 39(4):186-8. PubMed ID: 9676153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsuspected hypoglycaemia, haemoglobin A1 and diabetic control.
    Dornan TL; Peckar CO; Mayon-White VA; Knight AH; Moore RA; Hockaday TD; Bron AJ; Turner RC
    Q J Med; 1981; 50(197):31-8. PubMed ID: 7022541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia during insulin-induced hypoglycemia in a diabetic patient.
    Shimada R; Nakashima T; Nunoi K; Kohno Y; Takeshita A; Omae T
    Arch Intern Med; 1984 May; 144(5):1068-9. PubMed ID: 6370165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Severe hypoglycemia in diabetics with impaired renal function].
    Hasslacher C; Wittmann W
    Dtsch Med Wochenschr; 2003 Feb; 128(6):253-6. PubMed ID: 12571792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.